Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to compare the effects of recombinant factor VIIa (NovoSeven) on
restoring coagulation activation between patients with hemophilia A and antibodies to factor
VIII and normal subjects (controls) by use of an in vivo method.